📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma
Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]
Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]
This dataset investigates the effectiveness of p53 reactivation in treating glioblastoma. They achieve this by treating multiple patients with differing levels of MDM2 inhibitor [...]
This study aims to compare the epigenomes of different patient-derived models of colorectal cancer (PDO (Patient-Derived Organoid), PDX (Patient-Derived Xenograft), and PDOX (Patient-Derived Orthotopic [...]
Cut&Tag sequencing data from melanoma cells revealed that BAHCC1, a gene associated with Super-Enhancers (SE) and critical for cancer growth, is highly active compared [...]